BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
Pharmacogenetics
,
Phenobarbital
,
rs2476601
,
FGF21
,
calcium channel activity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Navitoclax
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with …
A navitoclax-loaded nanodevice targeting matrix metalloproteinase-3 for the selective elimination of…
Preventing spontaneous cerebral microhemorrhages in aging mice: a novel approach targeting cellular …
Combination of navitoclax (Bcl-2 and Bcl-xL inhibitor) and Debio-0932 (Hsp90 inhibitor) suppresses t…
Clearance of senescent cells by navitoclax (ABT263) rejuvenates UHMWPE-induced osteolysis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Combination of Olaparib and Navitoclax in Women With HGSC and TNBC
Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Hav…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ